Division of Nephrology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands.
Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands.
Nephrol Dial Transplant. 2014 Dec;29(12):2244-50. doi: 10.1093/ndt/gfu285. Epub 2014 Aug 28.
Infections are a major cause of morbidity and mortality among dialysis patients. Dialysis modality has been hypothesized to be a potential immunomodulatory factor. The objective of this study was to determine the influence of the first dialysis modality on the risk for infections on dialysis.
Our study was conducted utilizing the Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD) cohort of incident dialysis patients. Medical records of all patients from two tertiary care university hospitals and three regional hospitals were reviewed using pre-specified criteria. Information about infections was collected from the start of dialysis until death, modality switch, study withdrawal, kidney transplantation or at the end of the study. Age-standardized incidence rates for infections were calculated. Poisson regression analysis was used to calculate adjusted incidence rate ratios (IRRs).
In total, 452 patients, of whom 285 started with haemodialysis (HD) and 167 with peritoneal dialysis (PD), were included. The median follow-up time on the first dialysis modality was similar for HD and PD, 1.8 and 2.0 dialysis years, respectively. During the first 6 months, the age-standardized infection incidence rate was higher on HD compared with PD patients (P = 0.02). Overall, PD patients had a higher infection risk [adjusted IRR: 1.65, 95% confidence interval (CI): 1.34-2.03], which could be attributed to a 4-fold increased risk for dialysis technique-related infections. The risk for non-dialysis technique-related infections was lower in PD patients (adjusted IRR: 0.56, 95% CI: 0.40-0.79).
Overall, PD patients carry a higher risk for infections. Interestingly, the risk for non-dialysis technique-related infections was higher in HD patients. The links between dialysis modality and the immune system are expected to explain this difference, but future studies are needed to test these assumptions.
感染是透析患者发病率和死亡率的主要原因。透析方式被认为是潜在的免疫调节因素。本研究的目的是确定首次透析方式对透析患者感染风险的影响。
我们的研究利用了荷兰透析充分性合作研究(NECOSAD)的透析患者队列。使用预定标准回顾了来自两家三级护理大学医院和三家区域医院的所有患者的病历。从开始透析到死亡、模式转换、研究退出、肾移植或研究结束时,收集有关感染的信息。计算感染的年龄标准化发病率。使用泊松回归分析计算调整后的发病率比(IRR)。
共有 452 名患者,其中 285 名开始接受血液透析(HD),167 名开始接受腹膜透析(PD)。HD 和 PD 患者首次透析模式的中位随访时间相似,分别为 1.8 和 2.0 年。在前 6 个月,HD 患者的年龄标准化感染发病率高于 PD 患者(P = 0.02)。总体而言,PD 患者的感染风险更高[调整后的 IRR:1.65,95%置信区间(CI):1.34-2.03],这归因于与透析技术相关的感染风险增加了 4 倍。PD 患者与透析技术无关的感染风险较低(调整后的 IRR:0.56,95%CI:0.40-0.79)。
总体而言,PD 患者的感染风险更高。有趣的是,HD 患者与透析技术无关的感染风险更高。透析方式与免疫系统之间的联系有望解释这种差异,但需要进一步的研究来检验这些假设。